All posts

The Right Idea Still Needs the Right Room

A reflection on the first Unicorn Rodeo and what it takes to move technology across borders.

A unicorn belongs to the language of startups. A rodeo belongs to Texas. Put them together and you get a conference about what can happen when Israeli technology meets the people who can help it grow in the United States.

The first Unicorn Rodeo was held in Dallas and organized by the Texas-Israel Alliance in collaboration with The Jerusalem Post. It brought Israeli entrepreneurs together with Texas-based investors, scientists, business leaders, and policymakers. The program moved across biotechnology, artificial intelligence, energy, defense, and other emerging technologies, beginning with an invited-guest dinner and continuing with a full day of panels and conversations.

I was invited to attend both, and the most interesting part began before anyone stepped onto a stage.

At dinner, conversations moved quickly between science, investment, product development, and the realities of entering a new market. An idea could begin with synthetic biology and end with a discussion about validation, manufacturing, or the exact person who needed to join the next conversation.

That movement between worlds was the point.

In my first note, Product Development Is Mostly Translation, I wrote about the work required to move an idea between people, disciplines, and different definitions of success. At Unicorn Rodeo, I saw the same process happening between two countries and their technology communities.

A technology can be excellent and still go nowhere. The science may work, but the people building it still need to explain why it matters without making it sound simpler than it is. Investors need to understand what remains uncertain and whether that uncertainty can be resolved. Potential partners need enough technical understanding to recognize what is valuable before every question has an answer.

Throughout the event, I kept noticing how different strengths could fit together. There was a willingness to build early, test ambitious ideas, and work through uncertainty. There was also industrial experience, access to capital, and knowledge of what it takes to grow a company in the United States. I was less interested in comparing the two environments than in seeing what each could make possible for the other.

That connection did not feel abstract to me. I am Costa Rican, studied bioengineering in Texas, worked in Israel at Sheba Medical Center, and now build and evaluate technologies from Houston. Moving between countries and technical fields has made me pay attention to what changes when an idea enters a new context, and what must remain intact for the idea to still work.

Meeting Ben Lamm, founder of Colossal Biosciences, and Micha Breakstone, founder of Cellular Intelligence, was one of the highlights. Colossal is using genetic engineering in de-extinction and conservation, while Cellular Intelligence is combining artificial intelligence with cellular research and therapeutics.

Both companies begin with ideas ambitious enough to sound improbable. What impressed me was not only the size of those ideas, but the amount of practical thinking underneath them.

The more ambitious a technology is, the more carefully someone has to define the problem, decide what must be proven first, understand which risks actually matter, and bring together people who see different parts of the system.

I also liked that I was not in the room only to listen. I could contribute my own perspective from engineering, product development, and evaluating early-stage technologies. I have worked on both sides of the question: building something and deciding whether something is worth building. I naturally move between the technical details and the larger decisions surrounding them.

Can the idea work?

Who actually needs it?

What evidence is still missing?

What would make someone trust it?

What has to change before it can survive outside a laboratory or a pitch deck?

Those questions become even more important when technology crosses borders. A new market is not simply another place to sell the same product. It brings different users, regulations, institutions, incentives, and assumptions about how decisions are made. The science may remain the same while almost everything around it changes.

This is why international collaboration requires more than introductions. Someone has to understand enough of both contexts to notice what may be lost between them. A conversation can reveal a problem a founder did not know existed, connect technical work with an industry that needs it, or show that an idea has an application no one had considered yet.

That was what Unicorn Rodeo did particularly well. It did not simply place accomplished people in the same room. It gave them enough time to find the points where their work could connect.

I left Dallas thinking less about which company might become the next unicorn and more about how difficult ideas find the conditions they need to grow. A breakthrough can exist long before the right market, partner, or team appears around it.

The right idea still needs the right room.

Sometimes what is missing is not another invention. It is someone who can see where the pieces already in front of them belong.

I can let you know when the next one is up!

Leave your email here if you would like a note when I publish.